Dissociated Tumor Cells
LevitasBio developed a revolutionary levitation technology platform that uses less than 1 psi of pressure to enable a completely touch-free, label-free, enzyme-free, three-step dissociation process that produces high DTC yield without compromising or biasing cell type populations in the original microenvironment.
Viable DTCs are an integral component of therapeutic, diagnostic, and preclinical cancer research. Current methods used for sorting dissociated tumor cells take a certain level of finesse and technical expertise, time, and ample funding to produce sufficient yield and DTC viabilities that enable the analysis of these rare and sensitive cells.
The LeviCellTM’s 3-step, hands- and label-free platform enables the enrichment of DTCs while maintaining their gene expression and original sample representation ratio for accurate downstream analysis. This unique combination of technological features enables scientists and researchers to focus their effort and expertise on advancing their life-saving scientific knowledge and discoveries.